From The Editor

Explosive times
A
s the 19th century ran out of time, some respected
scientists were given to making pronouncements about
the coincident end of scientific discovery. “There is
nothing new to be discovered in physics now,” said the
renowned physicist Lord Kelvin, addressing the British
Association for the Advancement of Science in 1900. A quick
glance at the table of contents of this, the inaugural issue of the
Turkish Pharmaceutical Business Review, shows how wrong
he was.
We know of course that each day in science is a new day for
discovery. And medicine is no exception. See this issue’s Cover
File. Oncology, our centerpiece, is one of today’s fastest
growing, most profoundly important therapeutic areas. Who
among us cannot bear witness to the lethal, monstrous power
of cancer? The best scientific brains devote lifetimes in pursuit
of the cure, in pursuit of the dream. And every day we hear of
new medications, new medical advances, new types of targeted
therapies, and a new optimism generated by news of stem cell
research breakthroughs.
Certainly the field of scientific inquiry related to disease is
exploding… with new ideas, insights, opportunities, and hope.
And it is all for the good, for this brand of science is indeed for
the betterment of life, and nothing but.
This magazine intends to be a worldwide delivery platform of
information devoted to such a betterment of life. And its first
issue will be read in more than 70 countries. We have cast a
wide readership net to include academia, pharmaceutical
companies, governmental agencies, medical societies, and
health media outlet. And we particularly welcome industry
professionals in Europe, the Middle and Near East, and Africa.
Many of you know us already and we thank you for your generous
support during the incubation period of this magazine.
Reading through this first issue you will also notice an interview with
Dr. Alessandro Banchi, the CEO of Boehringer Ingelheim, the only
privately owned major pharmaceutical company. We are also pleased
to have three additional interviews from leading companies in one of
the fastest growing pharmaceutical markets in the world… Turkey!
Sedat Birol (Eczac›bafl›), Erman Atasoy (Abdi ‹brahim) and Levent
Selamo¤lu (MN Pharmaceuticals) appear in the Visions section and
tell us what they see.
Our deepest thanks go to Professor Recep Akda¤, Minister of Health
of Turkey. His sincere interest and support are profoundly
appreciated and his enthusiasm remains inspiring for us. And we
also thank Professor Ali ‹nsanov, Minister of Health of Azerbaijan.
We are delighted to publish their exclusive interviews in our
inaugural pages.
Indeed all these pages show the energy and scope of the relentless
advance of pharmaceutical science, all work dedicated to making a
healthier world. We are proud to share in that endeavor.
A final redemptive word about Lord Kelvin, indeed a great scientist
of his time. “You can understand anything,” he said, “if you put your
mind to it.”
We intend to do just that in chronicling the exciting business of
pharmaceuticals. 

James Ryan

Turkish Pharmaceutical Business Review • NOVEMBER - DECEMBER 2005 • Volume 1 - Issue 1 ISSN: 1306 - 2018

Editor in Chief: ‹brahim Erdo¤an, MD • Editor: James Ryan • Art Director: Ça¤dafl Gündo¤an • Illustrator: Tansel Körükçü • Photographer: Tezcan K›ld›ran

Contributors: Prof. Ahmet Erözenci, MD • Ardan Zentürk • Amber Little • Beyhan Nisa • Hakan Gürel • Hatice Bayrakdar • Burak Ravano¤lu • Sinem Soykan • Neslihan Alt›nkaya

Editorial: editor@pharmaceuticalbusinessreview.com Publisher: Rekmar Advertising and Brand Communications Limited

Advertising: advertise@pharmaceuticalbusinessreview.com Mailing Address: Leylak Sk Murat ‹fl Mrk B Blok K1 D7 Mecidiyeköy Istanbul 34387 Turkey
Subscriptions: subscribe@pharmaceuticalbusinessreview.com Phone: +90 212 266 2030 • Fax: +90 212 266 2033

Yay›n›n Ad›: Turkish Pharmaceutical Business Review • Yay›n Türü: Yayg›n Süreli (2 ay)• ‹mtiyaz Sahibi: Rekmar Reklam ve Marka ‹letiflim Hizmetleri Tic. Ltd. fiti. ad›na Ufuk M. Fak›o¤lu • Sorumlu Yaz› ‹flleri Müdürü: Dr. ‹brahim Erdo¤an
Yönetim Yeri: Leylak Sk Murat ‹fl Mrk B Blok K1 D7 Mecidiyeköy ‹stanbul 34387 Türkiye • Tel: +90 212 266 2030 • Faks: +90 212 266 2033 • Bask›: Promat Matbaac›l›k E5 Karayolu Üzeri Avc›lar ‹stanbul Türkiye • Tel: +90 212 690 6363

© Copyright 2005 Rekmar Advertising and Brand Communications Limited